ARTICLE AD BOX
As injectable GLP-1 medications become more widely used, many people wonder what happens when patients stop taking them outside of controlled clinical trials.
A new analysis from Cleveland Clinic, involving nearly 8,000 patients, suggests that stopping drugs like semaglutide and tirzepatide does not typically result in major weight regain in real-world settings. Many patients either restart treatment later or switch to other weight management options, which ma...

2 weeks ago
36








English (US) ·